← Back to Clinical Trials
Recruiting NCT07256548

NCT07256548 Machine Learning for Predicting Spinal Anesthesia Duration

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07256548
Status Recruiting
Phase
Sponsor Kocaeli City Hospital
Condition Spinal Anesthesia
Study Type OBSERVATIONAL
Enrollment 140 participants
Start Date 2025-10-31
Primary Completion 2026-02-14

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Spinal Anesthesia (bupivacaine)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 140 participants in total. It began in 2025-10-31 with a primary completion date of 2026-02-14.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Spinal anesthesia provides significant advantages over general anesthesia in knee arthroplasty, including reduced blood loss, faster recovery, and fewer complications. However, predicting its duration is critical for patient safety and effective postoperative management. This study evaluates the usability of machine learning (ML) algorithms to predict the termination time of spinal anesthesia and the patient's readiness for mobilization. Using demographic, surgical, and anesthetic variables, ML models were trained to estimate anesthesia duration. Accurate predictions may improve intraoperative planning, optimize postoperative care, and enhance patient outcomes. Integrating ML-based predictive systems into anesthesia practice can contribute to safer, more efficient, and personalized perioperative management.

Eligibility Criteria

Inclusion Criteria: 1. Patients scheduled to undergo total knee arthroplasty between November 2025 and March 2026 at the Kocaeli City Hospital Operating Theaters. 2. Patients who have provided written informed consent to participate in the study. 3. Patients whose surgery is planned under spinal anesthesia. 4. Patients for whom complete clinical data can be obtained during the study period. 5. Adults aged 18 years or older, classified as American Society of Anesthesiologist's (ASA) Physical Status I or II. Exclusion Criteria: 1. Patients who were converted to general anesthesia during surgery or initially operated under general anesthesia. 2. Patients who required postoperative intensive care unit (ICU) admission following anesthesia. 3. Patients who developed surgical complications and for whom postoperative mobilization could not be planned. 4. Patients with cognitive impairment preventing them from completing pain assessment scales in the postoperative period. 5. Patients with neuropathic pain, multiple sclerosis, or other neuromotor disorders will be excluded from the study.

Contact & Investigator

Central Contact

Sıddık Varolgüneş, MD

✉ varolgunes1235@gmail.com

📞 +905319179657

Principal Investigator

Ahmet Yüksek, MD

STUDY DIRECTOR

Kocaeli City Hospital

Frequently Asked Questions

Who can join the NCT07256548 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Spinal Anesthesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07256548 currently recruiting?

Yes, NCT07256548 is actively recruiting participants. Contact the research team at varolgunes1235@gmail.com for enrollment information.

Where is the NCT07256548 trial being conducted?

This trial is being conducted at Kocaeli, Turkey (Türkiye).

Who is sponsoring the NCT07256548 clinical trial?

NCT07256548 is sponsored by Kocaeli City Hospital. The principal investigator is Ahmet Yüksek, MD at Kocaeli City Hospital. The trial plans to enroll 140 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology